Here are the five latest drugs or medical devices approved by the Food and Drug Administration since August 4.
- Mavyret is intended to treat adults with all types of chronic hepatitis C virus with mild or no cirrhosis who have not previously received treatment for the
illness.
- Besponsa is used to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
- Vyxeos is intended to treat adults with two types of high-risk acute myeloid leukemia.
- Lynaparza may now be used for the ongoing treatment of patients with recurrent ovarian cancer who have responded to platinum-based chemotherapy.
- Serrato Pedicle Screw is intended for use in non-cervical procedures with the Xia 3 Spinal System.
More articles on supply chain:
7 must-reads for supply chain leaders this week
Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
CDC: Yellow fever vaccine out of stock